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The offspring of older fathers have an increased risk of neurodevelopmental disorders, such as schizophrenia and autism. In
lightoftheevidenceimplicatingcopynumbervariants(CNVs)withschizophreniaandautism,weusedamousemodeltoexplore
the hypothesis that the offspring of older males have an increased risk of de novo CNVs. C57BL/6J sires that were 3- and 12–16-
months old were mated with 3-month-old dams to create control offspring and offspring of old sires, respectively. Applying
genome-wide microarray screening technology, 7 distinct CNVs were identiﬁed in a set of 12 offspring and their parents.
Competitive quantitative PCR conﬁrmed these CNVs in the original set and also established their frequency in an independent
set of 77 offspring and their parents. On the basis of the combined samples, six de novo CNVs were detected in the offspring of
older sires, whereas none were detected in the control group. Two of the CNVs were associated with behavioral and/or
neuroanatomical phenotypic features. One of the de novo CNVs involved Auts2 (autism susceptibility candidate 2), and other
CNVs included genes linked to schizophrenia, autism and brain development. This is the ﬁrst experimental demonstration that
the offspring of older males have an increased risk of de novo CNVs. Our results support the hypothesis that the offspring of
older fathers have an increased risk of neurodevelopmental disorders such as schizophrenia and autism by generation of
de novo CNVs in the male germline.
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Introduction
Theoffspringofolderfathershaveanincreasedriskofarange
of neuropsychiatric disorders, including autism,
1 schizophre-
nia,
2,3 bipolar disorder
4 and epilepsy.
5 The mechanisms
underlying the increased risk of various neurodevelopmental
disorders in the offspring of older fathers remain unclear;
however, it has been proposed that de novo point mutations
and copy number variants (CNVs) in the continually dividing
spermatogonia in older males underlie this association.
2,6
Copy number variants refer to regions of the genome with
deletions, inversions or expansions of B1kb up to several
100kb in size.
7 These may occur throughout the genome, but
are enriched in regions ﬂanked by segmental duplication in
both humans
8,9 and mouse.
10,11 When CNVs encompass
genes, they can give rise to an increase or a decrease in gene
copy number, or they can contribute to the generation of
pseudogenes. CNVs have been associated with neuropsy-
chiatric disorders, including autism,
12–14 schizophrenia,
15–18
epilepsy
19,20 and mental retardation.
21,22 Carriers of such
CNVstendtopresentwithavariablephenotype,andanumber
of these CNVs can occur in apparently healthy individuals.
23
In light of the links between advanced paternal age (APA)
and neurodevelopmental disorders such as schizophrenia
and autism, various rodent-based models have been devel-
oped to explore the phenotypic correlates of APA.
24–26 On the
basis of an APA C57BL/6J mouse model, we have previously
reported that the offspring of older sires had subtle changes in
anxiety-related outcomesand changesin cortical thickness.
27
To date, we have not explored our model with respect to
de novo CNVs. In this preliminary study, we explored the
feasibility of CNV detection in our APA model. We hypo-
thesized that the offspring of older sires would have more
de novo CNVs than would the offspring of control sires. As the
offspring used in this study had also been assessed on
selected behavioral tests and structural magnetic resonance
imaging (MRI), we also had the opportunity to explore
phenotypic correlates of identiﬁed CNVs as a secondary
research question.
Materials and methods
Generation of control and APA families. Families with
control sires and those with old sires were generated as
described in detail elsewhere.
27 Virgin 3-month-old (control)
and 12–16-month-old (APA) male C57BL/6J mice were
selected to sire offspring; each was time mated with a
3-month-old female of the same strain. Offspring from
3-month-old males were used as controls, whereas
offspring from males aged 12–16 months comprised the
APA condition. Offspring were housed in groups of two to ﬁve
with littermates where possible, but always with offspring
from the same paternal condition. Mice were obtained from
the University of Queensland C57BL6/J (JAX) mouse stock,
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University of Queensland Animal Ethics Committee, under
the National Health and Medical Research Council of
Australia Guidelines. Further details are available in
Supplementary Material S1.
Array hybridization and detection of CNVs. Two arrays
were used in combination to identify CNVs. For genome-wide
screening, a commercially available microarray-based
Comparative Genomic Hybridization (aCGH) (Mouse
Genome CGH 244A Oligo Microarray, Agilent Technologies
Australia, Forest Hill, Victoria, Australia) was used, which
contained 236000 mapped 60-mer probes tiling the entire
mouse genome at an average distance of B11kb. CNVs
occur with higher frequency in the vicinity of segmental
duplication, and the genomic structure in these regions is
often complex in nature.
10 Furthermore, it becomes more
difﬁcult to distinguish a one-copy change in a target region
already present in multiple copies in the general population,
as the expected log(2) intensity ratio derived from a two-color
array decreases as a function of increasing reference copy
number. To address these considerations, a custom array
targeting CNVs identiﬁed recently by She et al.
28 in a
comprehensive comparison of different strains with C57BL/
6J was used. Designed by Dr S. Chong and printed by
Agilent, this array contained 11800 60-mer probes spread
over the genome at random and 15580 targeted probes
printed in duplicate. Selecting CNVs that could be targeted
with at least two pre-designed and computationally validated
probes, the custom array achieved 40% coverage of the
variant intervals mapped by She et al.
28 The resulting probe
spacing at CNV loci varied but averaged at 1.5kb.
Using these two arrays, we examined CNVs in two APA and
two control families (three offspring in each of the families and
equal number of sexes within each experimental group; total
offspringn¼12).Tocontrolforsexchromosomeloading,each
female test sample was competitively hybridized against a
commonfemalereferencesample,andeachmaletestsample
against a common male reference sample. A comparison of
the references allowed detection of any bias in autosomal and
pseudoautosomal regions where aberrations were identiﬁed
onthe arrays. Preparationandlabeling of genomicDNA, array
hybridization, scanning and feature extraction were performed
in accordance with the manufacturer’s recommended proto-
cols. Arrays were analyzed further using the Agilent DNA
Analytics v4.0.76 software to assure hybridization quality and
to detect aberrations. Detected aberrations were subjected to
furtherﬁlteringtoselectdistinctampliﬁcationsanddeletionsfor
further inspection. These procedures are described in detail in
Supplementary Material S1.
Validation and examination of candidate CNVs in an
independent sample. The candidate CNVs identiﬁed by
arrays were validated with Sequenom (Sequenom, QLD,
Australia), which combined competitive quantitative PCR and
matrix-assisted laser desorption/ionization-time of ﬂight
mass spectrometry
29,30 (see Supplementary Material S1).
In brief, assays were designed targeting regions of interest
(seven CNVs in total and four control regions without
genomic aberrations). CNV2 to CNV7 and control regions
were targeted by one assay each. CNV1 was targeted by
three assays. Using these same methods, we also evaluated
the prevalence of the selected CNVs in an independent
sample of 77 offspring. These additional offspring, which
were generated from 10 APA and 10 control breeding pairs,
included 18 APA female and 16 APA male offspring, as well
as 24 control female and 19 control male offspring. On the
basis of the combined samples, all families were carefully
evaluated for de novo CNV aberrations in offspring. A CNV
that was detected in an offspring but was not detected in
either parent was classiﬁed as ‘de novo’.
Behavioral and neuroanatomical phenotyping. Beha-
vioral phenotyping was conducted when the offspring were
10 weeks of age and on separate and consecutive days in
the following order: elevated plus maze, hole board, light/
dark emergence, 2-day forced swim test and 2-day novelty-
suppressed feeding. The order of testing was such that the
tests most sensitive to handling were performed ﬁrst
and those most stressful performed last. After 1 week of
free feeding, animals were tested on a 3-day active
avoidance and extinction protocol, tests for nociception
and prepulse inhibition of the acoustic startle response. All
behavioral observations were made blind to CNV status
and recorded from a central overhead camera, which was
attached to computerized tracking and event-recording
software, EthoVision version 3.1 (Noldus, Wageningen, The
Netherlands). Mice were acclimated to the testing room for 1h
before testing and all arenas and apparatus were cleaned
between trials with 20% ethanol. After completion of behavioral
testing, animals were killed with pentobarbitone and perfused
transcardially with 4% paraformaldehyde containing 1% of a
separate MRI contrast-enhancement agent, Magnevist
(gadopentetate dimeglumine; Schering AG, Berlin, Germany)
to optimize gray/white matter boundaries). Immediately before
imaging, the brains were suspended in fomblin. Animals were
imaged in the 16.4-T microimaging facility (Centre for Advanced
Imaging, University of Queensland). Using a 15-mm diameter
solenoid coil, fast-low action shot images were obtained in
three dimensions with 50-mm voxel resolution. Regions-of-
interest volumetric estimates were derived using the OsiriX
software package (Rosset; GNU General Public License) with
boundaries determined from a mouse brain atlas.
31 Brain
regions assessed included the hippocampus, striatum, septum,
corpus callosum and anterior commissure. All measurements
were made blind to CNV status and analyzed as proportions of
total brain volume. Further details of these measures are
described in a related publication.
27
Statistics and data analysis. We hypothesized that the
offspring of older sires would have signiﬁcantly more de novo
CNVs than would the offspring of control sires. On the basis
of the number of de novo CNVs in the offspring of the APA
and control groups, the odds ratio and 95% conﬁdence
interval (two-tailed) were calculated. As no CNVs were called
in the control offspring, we used the Haldane correction by
adding 0.5 to each cell in the table, to generate a ﬁnite odds
ratio. For phenotype assessments, all offspring (regardless
of paternal age) were assessed with either (1) t-tests, in
which we could clearly allocate CNV present versus absent
CNVs in the offspring of older males
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Translational Psychiatrystatus, or regression analyses between the relative copy
number and the outcome of interest, in which a CNV was
prevalent and hypervariable.
Bioinformatic analysis of detected CNVs. The expression
of genes in the mouse and the human brains was established
using the Allen Brain Atlas (http://www.brain-map.org/). The
CNV regions were mapped to the human genome using
the UCSC genome browser (http://genome.ucsc.edu/). The
association of these loci with human disease was established
with the Sullivan Lab Evidence Project (https://slep.unc.edu/
evidence/)
32 and the Online Mendelian Inheritance in Man
(http://www.ncbi.nlm.nih.gov/omim)
33,34 databases. The
occurrence of CNVs in the syntenic genomic regions in
humans in control cases and cases with neurocognitive
dysfunction was explored using the Database of Genomic
Variants (http://projects.tcag.ca/variation/project.html),
35,36
the DECIPHER (https://decipher.sanger.ac.uk/) and the
National Centre of Biotechnology Information (http://www.
ncbi.nlm.nih.gov/) databases.
Results
Identiﬁcation and prevalence of CNVs. Seven CNVs
were identiﬁed in the array-based sample. All of these CNVs
were successfully validated by Sequenom (Supplementary
Material S2). Each CNV contained or overlapped with at
least one gene (Table 1, Supplementary Material S3). The
prevalence of these CNVs in the combined samples is shown
in Figure 1. The prevalence of CNVs within the total cohort of
mice tested in this study (including the relationship of animals
to each other, the experimental group status and the individual
relative copy numbers (rCNs)) can be found in Supplementary
Material S4.
Both CNV1 and CNV7 were found to be prevalent and
hypervariable in both the parents and the offspring (the wide
distribution of rCN for these CNVs in Figure 1 must be noted).
Therefore, it was not possible to determine whether these
particularCNVsintheoffspringweredenovoorinherited.The
detailed counts for the remaining ﬁve CNVs are shown in
Table 2. On the basis of these CNVs, in the combined
samples, we identiﬁed a total of six de novo CNVs, in the
offspring of aged sires—one offspring with a deletion in
CNV2,fouroffspringwithdeletionsinCNV4andoneofCNV6.
The latter was a reversion of an X-linked region in a daughter
ofanagedsirewithanexpansioninthislocus(Supplementary
Material S4). No de novo CNVs were detected in the offspring
of control sires. We estimate that the offspring of aged sires
were 16 times more likely to have a de novo CNV compared
with the offspring of control sires (Haldane correction applied
to all counts; odds ratio and 95% conﬁdence intervals¼15.9,
2.2—undeﬁned, mid-P-exact¼0.005).
Correlation between CNV load and selected phenotypic
measures. We identiﬁed signiﬁcant correlates for two of
the CNVs with behavioral and MRI-derived neuroanato-
mical phenotypes. For CNV1 (a prevalent and hypervari-
able locus), offspring with higher rCN had signiﬁcantly
more avoidance responses (R¼0.489, F¼8.78, df¼28,
P¼0.006). For CNV6 (an X-linked locus) both behavioral and
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Translational Psychiatryneuroanatomical features were signiﬁcantly correlated
(see Figure 2). As expected, the X-linked CNV6 expansion
was only seen in female offspring. When compared with
CNV-negative APA females, those with CNV6 expansion had
a higher score for tail ﬂick (a measure related to pain
threshold; t(14)¼4.0, Po0.001) and higher scores on head
dip on the hole board test (a measure related to explora-
tory behavior; t(14)¼2.7, P¼0.02). With respect to the
MRI measures, those with CNV6 expansion had smaller
striatal (t (14)¼3.89, Po0.01) and hippocampal volumes
(t (14)¼4.84, Po0.01).
Bioinformatic analysis of syntenic regions in humans.
Copy number variant 1 spanned 33 characterized genes on
mouse chromosome 4 and their orthologs in the syntenic
region of this CNV in humans on chromosome 9. Within this
region, ampliﬁcations and deletions have been observed. A
gene encompassed by CNV1 (Sigmar1) has been asso-
ciated with alcoholism,
37 schizophrenia
38 and dementia.
39
Copynumbervariant2spannedexons3and4inthemouse
and the syntenic human Auts2gene (see Figure 3). This locus
has been associated with autism,
40 schizophrenia,
41 bipolar
disorder,
42 attention deﬁcit hyperactivity disorder
43 and
alcoholism.
44 Moreover, this gene was reported as differen-
tially methylated in a study on patients with schizophrenia and
major psychosis in schizophrenics.
45 Although several small
Figure 1 Relative copy number (rCN) in the combined samples established by Sequenom. rCN in the combined samples was examined by Sequenom competitive
quantitativePCR.ThedatafrombothsetsofanimalsareshownwithallvaluesscaledtosetarelativeCNof1at0.(a)VariationinCNV2wasestablishedusingthreeseparate
assays targeting the 50 prime, central or 30 prime region of this CNV, respectively. (b) The remaining CNVs were detected by one assay, each. CNV2–CNV6: Boxes denote
positive calls for ampliﬁcations or deletions. No formal assignment of calls was performed for the highly variable loci CNV1 and CNV7. CNV, copy number variant.
Table 2 Occurrence of CNV2, 3, 4, 5 and 6 in the combined samples
Parameter n CNV2 CNV3 CNV4 CNV5 CNV6
Advanced paternal age group
Sire 9 0 1 2 0 1
Dam 11 0 0 0 2 0
Female offspring 21 1 6 4 0 6
Male offspring 19 0 0 2 2 0
Sum 60 1 7 8 4 7
Control group
Sire 10 0 0 3 0 0
Dam 10 0 0 1 0 0
Female offspring 27 0 0 13 0 0
Male offspring 22 0 0 3 0 0
Sum 69 0 0 20 0 0
Total number of
animals (%)
129 1 (1) 14 (5) 28 (22) 8 (3) 14 (5)
De novo calls
Advanced paternal
age group
61 0 4 0 1
Control group 0 0 0 0 0 0
Abbreviation: CNV, copy number variant.
The number of sires, dams, male and female offspring tested in each
experimental group by either array and/or Sequenom is shown (n) together
with the number of those animals affected by an aberration.In addition, the total
number and proportion of all animals (%) affected and the number of de novo
calls for each CNV and each experimental group is detailed.
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Translational PsychiatryCNVs have been observed in the general population,
46–51
separate aberrations within this gene and overlapping with
CNV2 have been reported in cases with neurodevelopmental
disorders.
19,52–54 Balanced translocations disrupting Auts2
have been observed in additional cases with autism spectrum
disorder and mental retardation.
55 In addition, larger aberra-
tions encompassing Auts2 have been reported in cases with
mental retardation,
54,56–58 Zellweger’s syndrome
59 and social
cognitive delay.
60
For CNV4, three (Anxa11, Plac9 and D14Ertd449e) of the
ﬁve genes affected by this CNV mapped to human chromo-
some 10. One patient with schizophrenia
61 and two with
autism spectrum disorder
54 carried aberrations o600kb in
size that also contained these genes. CNV5 mapped to a
locus in human chromosome 8 that has been associated with
schizophrenia in a meta-analysis of genome-wide linkage
studies.
62 An aberration containing this region was present in
a patient with mental retardation.
54
Both CNV6 and CNV7 affected the Mid1 gene on
chromosome X. In the mouse, a pseudoautosomal boundary
is situated between exons 3 and 5 of Mid1.
63 The region
upstream of exon 3 is speciﬁc to the X chromosome, whereas
the region downstream of this exon is located on both sex
chromosomes.
63 The pseudoautosomal portion is highly
variable within C57BL/6J.
28,64,65 In our current study, CNV6
spanned exons 2 and 3 and is, therefore, X-linked. The two
breakpoints for CNV7 were between exons 3 and 4 and
B11kb downstream of this gene in the pseudoautosomal
region. CNV6 and CNV7 map to the same location in Mid1 in
humans, where the entire gene is X linked. Genetic loss of
function mutations in Mid1, has been found causative for the
Opitz G/BBB syndrome, which is characterized by a varied
phenotype that might include a range of midline birth defects
and mental retardation.
66 A patient with Opitz G/BBB
syndrome and autism carried a discrete deletion of Mid1 exon
2 (contained in CNV6).
67 A separate case with autism but
without Opitz G/BBB syndrome carried a duplication that
included the Mid1 gene from exon 2 onwards to a region
B500kb downstream of his gene.
68
Discussion
We report, for the ﬁrst time, experimental evidence indicating
that the offspring of older males have an increased risk of
de novo CNVs. Although the ﬁeld has long appreciated that
male germ cells would be at risk of more copy error mutations
compared with female germ cells,
69,70 the empirical evidence
has rested on the observation that particular types of
paternally derived translocations seem to be more common
in offspring of older men,
71,72 and studies that compared the
counts of candidate point mutations in the sperm of men of
different ages.
73,74 Here, we used a well-controlled mouse
modeltoinvestigatetheimpactofpaternalageonCNVsinthe
offspring. Although our sample size was small, we identiﬁed
six de novo CNVs in this study, and all de novo CNVs were in
the offspring of aged sires.
On the basis of detailed comparisons between C57BL/6J
andcloselyrelatedstrains,Eganetal.
65estimatedthatdenovo
CNVs occurred once in every 46–139 offspring. The lack of
de novo CNVs in the offspring of control animals is consistent
with these estimates. In contrast, for the offspring of aged
sires, we estimate that the incidence of de novo CNVs is once
in every six or seven offspring. Although we cannot be
certain that the de novo CNVs originated in the paternal
germline,becausetheageofthedamswasthesameinthetwo
groups, we would have expected an even distribution of
maternally derived mutations in the two groups. Similarly,
somatic mutations after fertilization should be equally repre-
sented in both groups. On the balance of probability, it is likely
that these CNVs were derived from the male germline. Future
studies could use dams and sires from different mouse
strains to allocate de novo CNVs to maternal or paternal
chromosomes.
With respect to the clinical relevance of our ﬁndings in
humans, our mouse model detected CNVs that impact on
genes previously linked to autism, schizophrenia and mental
retardation. Three of the CNVs occurred in regions of
prominent segmental duplication, which suggests that non-
allelic homologous recombination may underlie at least some
oftheage-relatedCNVs.Thetwoprevalentandhypervariable
CNVs (CNV1 and CNV7) are of interest and potentially
important for interpreting within-colony variation in this strain
of mouse. However, these may be less relevant to human
health outcomes as disease-related CNVs tend to be rare and
‘privileged’ within pedigrees.
23 It should also be noted that
mechanisms other than CNVs may contribute to the asso-
ciation between APA and increased risk of disorders, such as
schizophrenia and autism. For example, it is feasible that
epigenetic changes identiﬁed in sperm from older males
may also contribute to adverse health outcomes in the
offspring.
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Figure 2 Normalized values on CNV6 load—MRI and behavioral measures.
HB center time¼proportion of time spent in center zone of the hole board arena.
Avoidance response and head dip are count variables. Tail ﬂick and HB center time
are timed outcomes (in seconds). Startle response is average amplitude of
response to 120 decibels. MRI outcomes include volume of the striatum,
hippocampus and ventricles, and width of the corpus callosum. Statistically
signiﬁcantgroupdifferencesbyCNV6statusare shownwithan asterisk.CNV,copy
number variant; HB, hole board; MRI, magnetic resonance imaging.
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was exploratory in nature, the sample size was small, and we
used readily accessible technology to assess CNVs. The use
of (1) aCGH arrays with greater probe coverage, and/or deep
sequencing technology and (2) larger sample sizes, would
optimize more complete CNV discovery in our APA model.
Unfortunately, our experimental protocols required killing
animals for ex vivo MRI before the results of the CNV analysis
were completed, thus we were not able to establish breeding
lines from the offspring carrying APA-related de novo CNVs.
Adequate numbers of CNV-bearing offspring would
be required for optimal behavioral and neuroanatomical
phenotyping. Furthermore, the broad range of phenotypic
measuresused inour standardAPA screening batteryinvolve
many comparisons, inﬂating type I error (our results were not
adjusted for multiple comparisons). As such, the phenotypic
ﬁndings reported in this study should be considered explora-
toryinnatureandrequirereplicationinwell-poweredsamples.
Assequencingtechnologyimproves,itmayalsobefeasible
to examine the mechanism underpinning APA directly in the
sperm of young versus older males. Studies based on point
mutationsin a candidate gene havealready demonstratedthe
utility of this strategy in pooled sperm samples.
73,74 Further-
more, the mouse may not be the ideal species with respect
Figure 3 CNV2 details. (a) Array log(2) signal intensity ratios of the individual probes are plotted along mouse chromosome 5 and connected with a trend line based on
triangular smoothening. A de novo deletion (CNV2) affecting the Auts2 gene was detected in one female offspring of an old sire. The two purple lines depict the result of a
technical replicate with the animal containing the deletion. The black line visualizes the result obtained from a self-hybridization array, which was used to control for noise. The
location of the CNV on the mouse genome is boxed. (b) CNV2 was aligned to the human genome using the UCSC genome browser (http://genome.ucsc.edu/) together with
copy variants observed in the human and genomic regions associated with neurocognitive disease. HapMap: Case from the International Hapmap Project. SLEP, Sullivan
Laboratory Evidence Project; CNV, copy number variant; DEL, deletion; AMP, ampliﬁcation; DN, de novo.
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For example, the human genome contains slightly less
segmental duplication compared with the mouse (2.3 and
4.3%, respectively)
76 and is enriched for different types of
retrotransposal elements. As more human genomes are
sequenced (especially mother-father-offspring trios), and
CNVs are more accurately detected, we predict that the
offspring of older fathers will carry more de novo CNVs. It will
be of interest to explore the taxonomy of paternal age-related
CNVs and explore whether these mutations differentially
impact on neuropsychiatric health outcomes. It is feasible that
these mutations could ‘decanalize’ brain development and
increase the risk of neurodevelopmental disorders, such as
schizophrenia and autism.
77
The age of parenthood is increasing in many societies,
78
and thus it is feasible that the incidence of paternal-age
related de novo CNVs will increase over time. Worryingly,
these CNVs can be inherited and may accumulate over
several generations, with some clinical phenotypes ‘breaking
through’ only after a critical threshold of inherited and de novo
mutations have accumulated.
79 In light of the clues from
epidemiology linking APA to increased risk of schizophrenia
and autism, and given the convergent evidence linking rare
CNVs to these two disorders, the results of our study provide
a parsimonious biological mechanism that may contribute
to these disabling and poorly understood disorders.
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